Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent 

This 2019 review examines the in vivo and in vitro studies for the therapeutic and prophylactic effects of R. officinalis L. on some physiological disorders, Authors characterised active compounds to include: caffeic acid, carnosic acid, chlorogenic acid, monomeric acid, oleanolic acid, rosmarinic acid, ursolic acid, alpha-pinene, camphor, carnosol, eucalyptol, rosmadial, rosmanol, rosmaquinones A and B, secohinokio and derivatives of eugenol and luteolin. Health effects included (a) cardiac remodeling after myocardial infarction (b) body weight and dyslipidemia (c) cerebral ischemia (d) pain (e) infections (f) hepato-nephrotoxicity by lead (g) stress and anxiety and (h) tumor cells proliferation.

References:

de Oliveira, J. R., Camargo, S. E. A., & de Oliveira, L. D. (2019). Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent. Journal of biomedical science, 26(1), 5. https://doi.org/10.1186/s12929-019-0499-8